MétaCan
Menu
Back to cohort
Record W4397024465 · doi:10.1681/asn.20223311s1189a

Long-Term Outcomes in Eculizumab-Treated Patients Enrolled in the Global aHUS Registry

2022· article· en· W4397024465 on OpenAlexaff
Larry A. Greenbaum, Imad Al‐Dakkak, Ekaterina Anokhina, Gianluigi Ardissino, Gema Ariceta, Gurinder Kumar, Christoph Licht, Andrew M. Siedlecki, Johan Vande Walle

Bibliographic record

VenueJournal of the American Society of Nephrology · 2022
Typearticle
Languageen
FieldImmunology and Microbiology
TopicComplement system in diseases
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsEculizumabAtypical hemolytic uremic syndromeMedicineTerm (time)NephrologyPediatricsInternal medicineIntensive care medicineImmunologyComplement systemAntibody

Abstract

fetched live from OpenAlex

Background: The global atypical hemolytic uremic syndrome (aHUS) Registry (NCT01522183) is the largest repository of real-world data on patients with aHUS. We report long-term (LT) outcomes with eculizumab (ecu) treatment in two patient cohorts: those with LT follow-up (FU) without progression to end-stage kidney disease (ESKD) and those who developed ESKD during treatment. Our aim was to determine whether LT ecu preserves kidney function. Methods: The analysis included registry patients enrolled between Apr 2012-Nov 2021 and treated with ecu for ≥90 days. Cohort A included patients with ≥3-year FU, no ESKD, and two creatinine values; near treatment start and after ≥3-year observation. Cohort B included patients who developed ESKD after treatment with no FU duration specified. Results: Demographics and laboratory parameters (baseline [BL], last FU [LFU]) are shown in the Table. For Cohort A, 249 patients met inclusion criteria; at LFU, eGFR improved, 7% received acute dialysis (9% of adults, 6% of children) and two adults died. For Cohort B, 56 patients met inclusion criteria; at LFU, 48% received a kidney transplant (38% of adults, 68% of children), 89% received dialysis (95% of adults, 79% of children) and eight died (six adults, two children). BL eGFR was lower in patients who progressed to ESKD (Cohort B, N=56) than in patients who did not progress (Cohort A, N=249). Platelet and LDH levels improved in both cohorts at LFU. Conclusions: In a real-world setting, eGFR was stable in most patients receiving ecu. Some patients demonstrated hematologic benefits but no renal response; they had lower BL eGFR and initiated treatment late. Funding: Commercial Support - Alexion, AstraZeneca Rare Disease

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.378

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.282
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the American Society of NephrologySame topicComplement system in diseasesFrench-language works237,207